查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2023450

器官晶片平台市場分析與預測（至2035年）：按類型、產品、服務、技術、組件、應用、材料類型、最終用戶和功能分類

Organ-on-Chip Platforms Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, Material Type, End User, Functionality
出版日期: | 出版商: Global Insight Services | 英文 350 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

全球器官晶片平台市場預計將從2025年的3億美元成長到2035年的20億美元，複合年成長率（CAGR）為32.2%。預計到2026年，器官晶片平台的部署數量將超過15萬個。藥物研發（R&D）應用佔65%。與傳統模型相比，藥物測試的準確性提高了30-40%。北美佔48%的市場佔有率，部署量正以32%的複合年成長率快速成長。預計到2030年，超過50%的臨床前試驗將採用器官晶片技術，減少對動物試驗的依賴。

器官晶片平台正推動藥物研發領域的強勁成長，因為它們提供了一種更精準、更有效率的藥物反應測試方法。這些系統能夠模擬人體器官功能，使研究人員無需過度依賴動物實驗即可評估藥物的療效和毒性。製藥公司正在採用這項技術來提高研發成功率，同時縮短研發時間並降低成本。對個人化醫療日益成長的需求也推動了市場成長。隨著對先進測試方法的需求不斷增加，器官晶片平台正成為製藥業的關鍵創新，並正在改變傳統的藥物研發流程。

市場區隔
種類 肝臟晶片、心晶片、肺晶片、腎臟晶片、腸道晶片、腦晶片、皮膚晶片等等
產品 耗材、設備、軟體及其他
服務 諮詢、整合、維護及其他服務。
科技 微流體、3D細胞培養、生物列印及其他
成分 微晶片、微流控、感測器及其他
目的 藥物發現、毒性研究、疾病建模、個人化醫療等。
材料類型 聚合物、玻璃、矽、水凝膠及其他
最終用戶 製藥公司、學術和研究機構、生物技術公司、合約研究組織 (CRO) 及其他
功能 人體生理功能模擬、即時監測、高通量篩檢等。

微流體技術因其能夠在微觀層面精確控制流體流動而迅速發展。這使得微流控技術能夠精確模擬生物環境，使其成為器官晶片系統不可或缺的一部分。微加工和設計技術的不斷進步正在提升其性能和擴充性。隨著研發活動的增加，微流體技術正成為生物醫學領域創新中不可或缺的要素。其模擬複雜生理條件的能力正在推動其快速普及，並使其成為支撐器官晶片平台市場成長的關鍵技術。

區域概覽

北美地區憑藉其先進的生物醫學研究和強大的製藥實力，預計將在2025年引領器官晶片平台市場的發展。在美國，器官晶片模型在藥物測試和疾病研究中的日益普及推動了該技術的廣泛應用。領先的生物技術公司和研究機構的存在促進了創新。此外，監管機構對替代測試方法的支持正在減少對動物實驗的依賴。對個人化醫療日益成長的需求也進一步推動了市場成長。這些因素使得北美成為成長率最高的地區。

預計歐洲將成為成長最快的地區，這主要得益於人們對倫理研究實踐和先進醫療技術的日益重視。德國和英國等國正在投資器官晶片研究。精準藥物測試模型的需求不斷成長，推動了相關技術的應用。此外，政府資助以及學術機構與製藥公司之間的合作也為成長提供了支持。隨著減少動物實驗的呼聲日益高漲，歐洲的擴張速度進一步加快，使其成為全球成長最快的地區。

主要趨勢和促進因素

加速向非動物藥物測試模式的轉變：

由於藥物測試方法朝向符合倫理且不涉及動物的模式轉變，器官晶片平台市場正在蓬勃發展。製藥和生物技術公司正採用器官晶片系統來模擬人體器官功能，其精確度遠超傳統的動物模型。這些微型工程裝置能夠複製生理反應，從而提高藥物療效和毒性預測的準確性。監管機構也在推薦動物試驗的替代方案。隨著藥物研發對精準度的要求越來越高，器官晶片技術在減少試驗失敗和加速臨床研究方面的重要性日益凸顯，推動了全球市場的強勁成長。

微流體和組織工程技術的進展：

微流體和組織工程領域的技術進步是推動器官晶片平台市場發展的主要動力。晶片製造技術的創新使得對流體流動和細胞環境的精確控制成為可能，從而實現逼真的器官級模擬。幹細胞技術的整合提高了生物學精確性和擴充性。研究人員也正在開發多器官晶片系統，模擬複雜的人體相互作用。這些進步提高了藥物測試的可靠性並降低了研發成本。隨著生物醫學工程的不斷發展，器官晶片平台有望成為藥物研發和個人化醫療中不可或缺的工具。

目錄

第1章摘要整理

第2章 市場概覽

第3章 市場動態

  • 宏觀經濟分析
  • 市場趨勢
  • 市場促進因素
  • 市場機遇
  • 市場限制因素
  • 複合年均成長率：成長分析
  • 影響分析
  • 新興市場
  • 技術藍圖
  • 戰略框架

第4章：細分市場分析

  • 市場規模及預測：依類型
    • 肝片
    • 心形晶片
    • 肺晶片
    • 腎形片
    • 腸片
    • 腦晶片
    • 皮膚碎片
    • 其他
  • 市場規模及預測：依產品分類
    • 消耗品
    • 裝置
    • 軟體
    • 其他
  • 市場規模及預測：依服務分類
    • 諮詢
    • 一體化
    • 維護
    • 其他
  • 市場規模及預測：依技術分類
    • 微流體
    • 3D細胞培養
    • 生物列印
    • 其他
  • 市場規模及預測：依組件分類
    • 微晶片
    • 微流控
    • 感應器
    • 其他
  • 市場規模及預測：依應用領域分類
    • 藥物發現
    • 毒性研究
    • 疾病建模
    • 個人化醫療
    • 其他
  • 市場規模及預測：依材料類型分類
    • 聚合物
    • 玻璃
    • 矽
    • 水凝膠
    • 其他
  • 市場規模及預測：依最終用戶分類
    • 製藥公司
    • 學術和研究機構
    • 生技公司
    • CRO（委外研發機構）
    • 其他
  • 市場規模及預測：依功能分類
    • 人體生理功能模擬
    • 即時監控
    • 高通量篩檢
    • 其他

第5章 區域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲
  • 亞太地區
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲
    • 亞太其他地區
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • 其他中東和非洲地區

第6章 市場策略

  • 供需差距分析
  • 貿易和物流限制
  • 價格、成本和利潤率趨勢
  • 市場滲透率
  • 消費者分析
  • 監管概述

第7章 競爭訊息

  • 市場定位
  • 市場占有率
  • 競爭基準
  • 主要企業的策略

第8章：公司簡介

  • Emulate
  • CN Bio Innovations
  • TissUse
  • Mimetas
  • Hesperos
  • Tara Biosystems
  • InSphero
  • Kirkstall
  • Nortis
  • AxoSim
  • BiomimX
  • Hurel Corporation
  • Cherry Biotech
  • AlveoliX
  • Elveflow
  • Micronit
  • SynVivo
  • Organovo
  • Draper
  • Altis Biosystems

第9章：關於Global Insight Services

簡介目錄
Product Code: GIS34486

The global organ-on-chip platforms market is projected to grow from $0.3 billion in 2025 to $2.0 billion by 2035, at a compound annual growth rate (CAGR) of 32.2%. Organ-on-chip platforms are expected to exceed 150,000 units in deployment by 2026. Pharmaceutical R&D accounts for 65% of usage. Drug testing accuracy improves by 30-40% compared to traditional models. North America holds 48% share. Adoption is growing at 32% CAGR. By 2030, over 50% of preclinical testing is expected to incorporate organ-on-chip technologies, reducing reliance on animal testing.

Drug discovery is driving strong growth as organ-on-chip platforms provide more accurate and efficient methods for testing drug responses. These systems simulate human organ functions, allowing researchers to evaluate drug efficacy and toxicity without relying heavily on animal testing. Pharmaceutical companies are adopting this technology to reduce development time and costs while improving success rates. Increasing demand for personalized medicine is also supporting growth. As the need for advanced testing methods continues to rise, organ-on-chip platforms are becoming a key innovation in the pharmaceutical industry, transforming traditional drug development processes.

Market Segmentation
TypeLiver-on-Chip, Heart-on-Chip, Lung-on-Chip, Kidney-on-Chip, Intestine-on-Chip, Brain-on-Chip, Skin-on-Chip, Others
ProductConsumables, Instruments, Software, Others
ServicesConsulting, Integration, Maintenance, Others
TechnologyMicrofluidics, 3D Cell Culture, Bioprinting, Others
ComponentMicrochips, Microfluidic Channels, Sensors, Others
ApplicationDrug Discovery, Toxicology Research, Disease Modeling, Personalized Medicine, Others
Material TypePolymers, Glass, Silicon, Hydrogels, Others
End UserPharmaceutical Companies, Academic Research Institutes, Biotechnology Companies, Contract Research Organizations, Others
FunctionalityMimicking Human Physiology, Real-time Monitoring, High-throughput Screening, Others

Microfluidics technology is expanding rapidly due to its ability to precisely control fluid flow at a microscopic level. This enables accurate simulation of biological environments, making it essential for organ-on-chip systems. Continuous advancements in microfabrication and design are improving performance and scalability. As research and development activities increase, microfluidics is becoming a critical component in biomedical innovation. Its ability to replicate complex physiological conditions is driving rapid adoption, making it a key technology supporting the growth of the organ-on-chip platforms market.

Geographical Overview

North America leads the organ-on-chip platforms market in 2025 due to advanced biomedical research and strong pharmaceutical industry presence. The United States drives adoption with increasing use of organ-on-chip models for drug testing and disease research. The presence of leading biotech firms and research institutions enhances innovation. Additionally, regulatory support for alternative testing methods reduces reliance on animal testing. Growing demand for personalized medicine further boosts growth. These factors position North America as the highest growing regional market.

Europe is projected to be the fastest growing region due to increasing focus on ethical research practices and advanced healthcare technologies. Countries like Germany and the UK are investing in organ-on-chip research. Rising demand for accurate drug testing models drives adoption. Additionally, government funding and collaboration between academic institutions and pharmaceutical companies support growth. Increasing emphasis on reducing animal testing further accelerates expansion, making Europe the fastest growing region globally.

Key Trends and Drivers

Rising Shift Toward Animal-Free Drug Testing Models:

The Organ-on-Chip Platforms Market is growing due to the increasing shift toward ethical, animal-free drug testing methods. Pharmaceutical and biotechnology companies are adopting organ-on-chip systems to simulate human organ functions more accurately than traditional animal models. These microengineered devices replicate physiological responses, enabling better prediction of drug efficacy and toxicity. Regulatory agencies are also encouraging alternatives to animal testing. As drug development becomes more precision-driven, organ-on-chip technology is gaining importance for reducing trial failures and accelerating clinical research processes, thereby driving strong market growth globally.

Advancements in Microfluidics and Tissue Engineering Technologies:

Technological advancements in microfluidics and tissue engineering are key drivers of the Organ-on-Chip Platforms Market. Innovations in chip fabrication allow precise control of fluid flow and cellular environments, enabling realistic organ-level simulations. Integration of stem cell technology is improving biological accuracy and scalability. Researchers are also developing multi-organ chip systems to replicate complex human interactions. These advancements are enhancing drug testing reliability and reducing development costs. As biomedical engineering progresses, organ-on-chip platforms are expected to become essential tools in pharmaceutical research and personalized medicine.

Research Scope

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Strategic Recommendations
  • 1.5 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by Material Type
  • 2.8 Key Market Highlights by End User
  • 2.9 Key Market Highlights by Functionality

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Technologies Landscape
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Liver-on-Chip
    • 4.1.2 Heart-on-Chip
    • 4.1.3 Lung-on-Chip
    • 4.1.4 Kidney-on-Chip
    • 4.1.5 Intestine-on-Chip
    • 4.1.6 Brain-on-Chip
    • 4.1.7 Skin-on-Chip
    • 4.1.8 Others
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Consumables
    • 4.2.2 Instruments
    • 4.2.3 Software
    • 4.2.4 Others
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Consulting
    • 4.3.2 Integration
    • 4.3.3 Maintenance
    • 4.3.4 Others
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Microfluidics
    • 4.4.2 3D Cell Culture
    • 4.4.3 Bioprinting
    • 4.4.4 Others
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Microchips
    • 4.5.2 Microfluidic Channels
    • 4.5.3 Sensors
    • 4.5.4 Others
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Drug Discovery
    • 4.6.2 Toxicology Research
    • 4.6.3 Disease Modeling
    • 4.6.4 Personalized Medicine
    • 4.6.5 Others
  • 4.7 Market Size & Forecast by Material Type (2020-2035)
    • 4.7.1 Polymers
    • 4.7.2 Glass
    • 4.7.3 Silicon
    • 4.7.4 Hydrogels
    • 4.7.5 Others
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Pharmaceutical Companies
    • 4.8.2 Academic Research Institutes
    • 4.8.3 Biotechnology Companies
    • 4.8.4 CROs
    • 4.8.5 Others
  • 4.9 Market Size & Forecast by Functionality (2020-2035)
    • 4.9.1 Mimicking Human Physiology
    • 4.9.2 Real-time Monitoring
    • 4.9.3 High-throughput Screening
    • 4.9.4 Others

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 Material Type
      • 5.2.1.8 End User
      • 5.2.1.9 Functionality
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 Material Type
      • 5.2.2.8 End User
      • 5.2.2.9 Functionality
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 Material Type
      • 5.2.3.8 End User
      • 5.2.3.9 Functionality
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 Material Type
      • 5.3.1.8 End User
      • 5.3.1.9 Functionality
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 Material Type
      • 5.3.2.8 End User
      • 5.3.2.9 Functionality
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 Material Type
      • 5.3.3.8 End User
      • 5.3.3.9 Functionality
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 Material Type
      • 5.4.1.8 End User
      • 5.4.1.9 Functionality
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 Material Type
      • 5.4.2.8 End User
      • 5.4.2.9 Functionality
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 Material Type
      • 5.4.3.8 End User
      • 5.4.3.9 Functionality
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 Material Type
      • 5.4.4.8 End User
      • 5.4.4.9 Functionality
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 Material Type
      • 5.4.5.8 End User
      • 5.4.5.9 Functionality
    • 5.4.6 Rest of APAC
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 Material Type
      • 5.4.6.8 End User
      • 5.4.6.9 Functionality
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 Material Type
      • 5.5.1.8 End User
      • 5.5.1.9 Functionality
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 Material Type
      • 5.5.2.8 End User
      • 5.5.2.9 Functionality
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 Material Type
      • 5.5.3.8 End User
      • 5.5.3.9 Functionality
    • 5.5.4 Italy
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 Material Type
      • 5.5.4.8 End User
      • 5.5.4.9 Functionality
    • 5.5.5 Rest of Europe
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 Material Type
      • 5.5.5.8 End User
      • 5.5.5.9 Functionality
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 Material Type
      • 5.6.1.8 End User
      • 5.6.1.9 Functionality
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 Material Type
      • 5.6.2.8 End User
      • 5.6.2.9 Functionality
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.5.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 Material Type
      • 5.6.3.8 End User
      • 5.6.3.9 Functionality
    • 5.6.4 Rest of MEA
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 Material Type
      • 5.6.4.8 End User
      • 5.6.4.9 Functionality

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Emulate
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 CN Bio Innovations
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 TissUse
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Mimetas
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Hesperos
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Tara Biosystems
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 InSphero
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Kirkstall
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Nortis
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 AxoSim
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 BiomimX
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Hurel Corporation
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Cherry Biotech
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 AlveoliX
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Elveflow
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Micronit
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 SynVivo
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Organovo
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Draper
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Altis Biosystems
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us